Recent Advances in Tissue plasminogen activator-based nanothrombolysis for ischemic stroke

Recent Advances in Tissue plasminogen activator-based nanothrombolysis for ischemic stroke

Stroke is an acute cerebrovascular disorder caused by sudden decrease or interruption of blood flow in brain arteries. Deficiency of timely and effective reperfusion of ischemic brain tissue can lead to irreversible brain injury and neurological dysfunction. Currently, recombinant tissue plasminogen...

Full description

Bibliographic Details
Main Authors: Huang Dongdong, Wu Ke, Zhang Ying, Ni Zhihui, Zhu Xiaohong, Zhu Can, Yang Jianjing, ZhuGe Qichuan, Hu Jiangnan
Format: Article
Language:English
Published: De Gruyter 2019-09-01
Series:Reviews on Advanced Materials Science
Subjects:
tissue plasminogen activator
drug delivery
nanomaterial
stroke
thrombolysis
Online Access:https://doi.org/10.1515/rams-2019-0024

Internet

https://doi.org/10.1515/rams-2019-0024

Similar Items